Researchers identified a protein in mouse models that acts as a brake on myelin production, which could be a target for new ...
News-Medical.Net on MSN
First multiple sclerosis patient in the UK receives CAR T cell therapy in groundbreaking trial
A multiple sclerosis (MS) patient in the UK was the first to receive CAR T cell therapy, invented by UCL researchers, in a ...
Once-yearly infusions of rituximab are as effective as twice-yearly dosing for sustained control of MS in a new phase 3 trial ...
Doctors are looking to recruit more people for the trial, which they say could one day be given as a single one-off treatment ...
With ads everywhere for pro- or pre-biotic foods and supplements, most people are familiar with the gut microbiome—the ...
By the time patients start seeking care for multiple sclerosis (MS), the disease has already been damaging their brains for ...
UCSF study finds MS starts damaging the brain years before symptoms appear. Early immune attack on myelin and key proteins ...
Researchers have traced the earliest stages of multiple sclerosis (MS), showing that the immune system begins attacking the brain up to seven years before diagnosis.
Women with multiple sclerosis, particularly after menopause, experience a higher risk of relapse-independent worsening, whereas men have a greater worsening of disability with every event.
It’s also worth noting that even if you have MS disability benefits through Social Security, you do not automatically receive ...
Multiple sclerosis, which affects around one in 500 people in Switzerland, is an autoimmune disease in which immune cells ...
Scientists have found that people with multiple sclerosis (MS) have a distinctly imbalanced oral microbiome—marked by a loss of beneficial bacteria and a rise in inflammation-linked microbes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results